Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5567067 | 0.83 | ALDH1A1 (0.52) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL969883 | 0.82 | CYP3A4 (0.39) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4188074 | 0.82 | ALDH1A1 (0.34) | ALDH1A1TDP1CYP3A4TSHRL3MBTL1 | |
| SCHEMBL665109 | 0.80 | — | — | |
| SCHEMBL4183656 | 0.76 | CYP3A4 (0.39) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4188071 | 0.75 | CYP3A4 (0.34) | ALDH1A1CYP3A4CA2L3MBTL1FDPS | |
| SCHEMBL989187 | 0.74 | CYP3A4 (0.33) | ALDH1A1CYP3A4CA2L3MBTL1FDPS | |
| SCHEMBL11402157 | 0.73 | CYP3A4 (0.41) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4193287 | 0.72 | ALDH1A1 (0.40) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL8019102 | 0.71 | ALDH1A1 (0.48) | ALDH1A1TDP1CYP3A4TSHRCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2029613-B1 | NOVEL PHOSPHINIC ACIDS AND THEIR SULFUR DERIVATIVES AND METHODS FOR THEIR PREPARATION | CYTEC CANADA INC (CA) | 2016-07-20 | — | — | EP | claimed |
| US-20140275615-A1 | NOVEL PHOSPHINIC ACIDS AND THEIR SULFUR DERIVATIVES AND METHODS FOR THEIR PREPARATION | CYTEC TECHNOLOGY CORP. (US) | 2014-09-18 | — | — | US | claimed |
| US-20090165598-A1 | NOVEL PHOSPHINIC ACIDS AND THEIR SULFUR DERIVATIVES AND METHODS FOR THEIR PREPARATION | CYTEC CANADA INC. (CA) | 2009-07-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275615-A1 | NOVEL PHOSPHINIC ACIDS AND THEIR SULFUR DERIVATIVES AND METHODS FOR THEIR PREPARATION | PHOSPHO1, PRDX2, PRDX1 | ALDH1A1 2940/4885TDP1 3464/4885CYP3A4 4229/4885 |
| US-20090165598-A1 | NOVEL PHOSPHINIC ACIDS AND THEIR SULFUR DERIVATIVES AND METHODS FOR THEIR PREPARATION | PRDX2, PRDX1, PRDX6 | ALDH1A1 2637/4885TDP1 3540/4885CYP3A4 4136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.